SCYNEXIS

SCYNEXIS Diluted EPS

The Diluted Earnings per Share of SCYNEXIS (SCYX) as of Sep 27, 2026 is -1.58 USD. In the previous year, Diluted Earnings per Share was -4.48 USD — a change of -64.73% (higher).

Diluted EPS

-1.58USD

YoY

-64.73%

Last updated:

Diluted Earnings per Share of SCYNEXIS is 2026 -1.58 USD. Diluted Earnings per Share of SCYNEXIS was 2025 -4.48 USD. It decreases by -64.73% higher compared to the previous year.

The SCYNEXIS Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-20.79 USD
Jan 1, 2019
-63.64 USD
Jan 1, 2020
-40.48 USD
Jan 1, 2021
-9.43 USD
Jan 1, 2022
-15.37 USD
Jan 1, 2023
14.41 USD
Jan 1, 2024
-4.48 USD
Jan 1, 2025
-1.58 USD
The SCYNEXIS Diluted EPS history
YEARDiluted EPSYoY
-1.58USD-64.73%
-4.48USD-131.11%
14.41USD-193.76%
-15.37USD+62.99%
-9.43USD-76.70%
-40.48USD-36.39%
-63.64USD+206.04%
-20.79USD+140.40%
-8.65USD-26.84%
-11.82USD-93.70%
-187.70USD+372.14%
-39.76USD—
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Diluted Earnings per Share of SCYNEXIS is -1.58 USD in 2026.

Diluted Earnings per Share of SCYNEXIS changed from -4.48 USD to -1.58 USD, representing a -64.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

Income Statement — SCYNEXIS

All Key Metrics — SCYNEXIS